Status
Conditions
Treatments
About
Clinical information and samples (blood, saliva, and tumor) will be collected from patients with multiple cancers and/or a family history of cancer as well as from affected and unaffected relatives; samples will be systematically sequenced and evaluated for candidate driver mutations.
Full description
Genetic screening will be performed on DNA (and/or RNA) isolated from collected samples from affected individuals by whole exome sequencing or RNA sequencing using in-house pipeline to identify candidate sequence variants. These variants will be tested for segregation with the phenotype in other relatives (affected/unaffected). Candidate variants will be subjected to additional downstream analysis, to be guided by the actual type of gene/variant.
Enrollment
Sex
Volunteers
Inclusion criteria
Any age
Meets at least ONE of the following:
Exclusion criteria
Loading...
Central trial contact
Patricia L Dahia, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal